###begin article-title 0
The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults
###end article-title 0
###begin p 1
Conceived and designed the experiments: PS. Analyzed the data: GP LS JW JPC AH PS. Wrote the paper: GP LS JW JPC AH PS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The genetic basis of haemorrhagic stroke has proved difficult to unravel, partly hampered by the small numbers of subjects in any single study. A meta-analysis of all candidate gene association studies of haemorrhagic stroke (including ruptured subarachnoid haemorrhage and amyloid angiopathy-related haemorrhage) was performed, allowing more reliable estimates of risk.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
A systematic review and meta-analysis of all genetic studies in haemorrhagic stroke was conducted. Electronic databases were searched until and including March 2007 for any candidate gene in haemorrhagic stroke. Odds ratio (OR) and 95% confidence intervals (CI) were determined for each gene disease association using fixed and random effect models.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Our meta-analyses included 6,359 cases and 13,805 controls derived from 55 case-control studies, which included 12 genes (13 polymorphisms). Statistically significant associations with haemorrhagic stroke were identified for those homozygous for the ACE/I allele (OR, 1.48; 95% CI, 1.20-1.83; p = 0.0003) and for the 5G allele in the SERPINE1 4G/5G polymorphism (OR, 1.42; 95% CI, 1.03-1.96; p = 0.03). In addition, both &b.epsi;2 and &b.epsi;4 alleles of APOE were significantly associated with lobar haemorrhage (OR, 1.81; 95% CI, 1.26-2.62; p = 0.002 and OR, 1.49; 95% 1.08-2.05; p = 0.01 respectively). Furthermore, a significant protective association against haemorrhagic stroke was found for the factor V Leiden mutation (OR, 0.30; 95% CI, 0.10-0.87; p = 0.03).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Our data suggests a genetic contribution to some types of haemorrhagic stroke, with no overall responsible single gene but rather supporting a polygenic aetiology . However, the evidence base is smaller compared to ischaemic stroke. Importantly, for several alleles previously found to be associated with protection from ischaemic stroke, there was a trend towards an increased risk of haemorrhagic stroke.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 145 148 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-ElSaed1">[1]</xref>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Rosamond1">[2]</xref>
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Dennis1">[3]</xref>
###xml 580 583 580 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Sutherland1">[4]</xref>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
Haemorrhagic stroke accounts for approximately 13% of all stroke and is associated with a mortality rate four times higher than ischaemic stroke,[1], [2] with only 38% of haemorrhagic stroke patients surviving beyond the first year.[3] Intracranial haemorrhage can be subdivided into extradural, subdural, subarachnoid, intraventricular and intracerebral (with/without subarachnoid and/or intraventricular) haemorrhage. Primary intracerebral haemorrhage (ICH) originates from the spontaneous rupture of small vessels damaged by chronic hypertension or cerebral amyloid angiopathy,[4] while secondary intracerebral haemorrhage is most commonly associated with subarachnoid haemorrhage (SAH)_due to ruptured intracranial aneurysms or ruptured arteriovenous malformations. Haemorrhage from rupture of hypervascular tumors or impaired coagulation occurs in a very small proportion of cases while traumatic related haemorrhage tends to have different characteristics.
###end p 11
###begin p 12
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Ariyaratnam1">[5]</xref>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Casas1">[6]</xref>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Alberts1">[7]</xref>
###xml 935 938 935 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Bromberg1">[8]</xref>
###xml 940 943 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Gaist1">[9]</xref>
###xml 1116 1120 1116 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Schievink1">[10]</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Ronkainen1">[11]</xref>
###xml 547 555 <span type="species:ncbi:9606">patients</span>
###xml 801 809 <span type="species:ncbi:9606">patients</span>
###xml 961 969 <span type="species:ncbi:9606">patients</span>
Although significant progress has been made towards unraveling the basis of single gene stroke disorders and common ischaemic stroke [5], [6], identifying the underlying genes for multifactorial haemorrhagic stroke for which there is no obvious Mendelian pattern of inheritance, has proved difficult. This is despite the evidence for a genetic contribution towards haemorrhagic stroke being considerable (with a likely greater genetic effect for SAH compared to ICH). Stroke cases have also been found to cluster in families. Approximately 10% of patients with intracerebral haemorrhage have a positive family history of haemorrhagic stroke [7], and having a first-degree relative with intracerebral haemorrhage has been found to be a risk factor for developing the disease. First degree relatives of patients with subarachnoid haemorrhage have up to a seven-fold increased risk of subarachnoid haemorrhage than the general population,[8], [9] and about 10% of patients with aneurysmal subarachnoid haemorrhage have a first or second degree relative with subarachnoid haemorrhage or unruptured intracranial aneurysm.[10], [11]
###end p 12
###begin p 13
###xml 251 254 251 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Casas1">[6]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Dichgans1">[12]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Ioannidis1">[13]</xref>
Genetic association studies in haemorrhagic stroke have identified a considerable number of candidate genes, however, due to lack of reproducibility, uncertainty remains about the nature and number of genes contributing to risk of haemorrhagic stroke.[6] There is concern, on one hand, that positive associations might be spurious and, on the other hand, that the negative findings from some studies might be a consequence of inadequate statistical power from small sample size or methodological shortcomings, such as selection of inappropriate control groups.[12], [13] The use of a genetic meta-analysis strategy overcomes some of these limitations, although the results are limited by the available data. Therefore, in this study a comprehensive literature-based meta-analysis of all published association studies in mainly primary intracerebral and aneurysmal subarachnoid forms of haemorrhage was undertaken.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Data sources
###end title 15
###begin p 16
###xml 199 205 <span type="species:ncbi:9606">humans</span>
Electronic searches initially using PubMed, Embase and Google Scholar were used to identify published genetic association studies evaluating any candidate gene and any form of haemorrhagic stroke in humans published until and including March 2007. Letters and abstracts were included in the searches.
###end p 16
###begin p 17
###xml 70 89 70 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haemorrhagic stroke</italic>
###xml 91 116 91 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">intracerebral haemorrhage</italic>
###xml 118 142 118 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">intracranial haemorrhage</italic>
###xml 144 168 144 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">subarachnoid haemorrhage</italic>
###xml 170 191 170 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">intracranial aneurysm</italic>
###xml 193 217 193 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aneurysmal h(a)emorrhage</italic>
###xml 219 245 219 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arteriovenous malformation</italic>
###xml 247 275 247 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cerebrovascular malformation</italic>
###xml 277 294 277 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cavernous angioma</italic>
###xml 299 326 299 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cerebral amyloid angiopathy</italic>
###xml 347 359 347 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gene</italic>
###xml 367 375 367 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">genotype</italic>
###xml 379 387 379 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mutation</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">human</italic>
###xml 594 610 594 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">related articles</italic>
###xml 421 426 <span type="species:ncbi:9606">human</span>
The Medical Subject Headings and text words used for the search were: haemorrhagic stroke, intracerebral haemorrhage, intracranial haemorrhage, subarachnoid haemorrhage, intracranial aneurysm, aneurysmal h(a)emorrhage, arteriovenous malformation, cerebrovascular malformation, cavernous angioma and cerebral amyloid angiopathy in combination with polymorphism, gene, genotype or mutation. Search results were limited to 'human'. All languages were searched and translated when necessary. The references of all identified publications were searched for additional studies and the MEDLINE option related articles was used to examine all relevant articles.
###end p 17
###begin title 18
Study selection
###end title 18
###begin p 19
###xml 403 423 403 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Control populations:</italic>
###xml 1179 1187 <span type="species:ncbi:9606">patients</span>
###xml 1193 1201 <span type="species:ncbi:9606">children</span>
Selection criteria included case-control or cohort studies where stroke was analyzed as a dichotomous trait. Studies were selected if neuroimaging (magnetic resonance imaging, computerised tomography or angiography) or autopsy had been used to confirm a diagnosis of intracerebral haemorrhage, subarachnoid haemorrhage, ruptured intracranial aneurysm or cerebral amyloid angiopathy-related haemorrhage. Control populations: The vast majority of the time subjects classified as 'controls' had not been subjected to neuro-imaging with investigators assuming that any haemorrhage would be clinically detectable. Different sub-types of haemorrhages were combined on the basis that its aetiology, in the broadest sense, is vessel damage. Moreover, most investigators in our study combined such data. However, haemorrhagic sub-type data was analyzed separately where possible, e.g. Factor V Leiden. Studies of all ethnic backgrounds were included. Genes with three or more publications on each SNP were included in our analyses but, if very large numbers of subjects were identified in only two studies dealing with a solitary SNP these were included. Studies were excluded if (1) the patients were children (aged <18 years), (2) genotype frequency was not adequately reported (and such data could not be obtained from the authors), (3) genotype frequency of haemorrhagic stroke sub-types were not reported independently from ischaemic stroke cases, (4) cases due to trauma, haemorrhagic rupture of tumour or haemorrhagic conversion of ischaemic stroke were included in case genotype frequencies, or (5) quantitative traits or intermediate phenotypes were investigated. Data from SNP investigated in three or more studies are presented.
###end p 19
###begin title 20
Data extraction
###end title 20
###begin p 21
###xml 361 369 <span type="species:ncbi:9606">patients</span>
The first pass data extraction was undertaken by GP. Several subsequent passes were then undertaken by GP and PS to ensure comprehensive inclusion of appropriate studies. Once studies were identified data was extracted initially by GP and then checked by PS. For studies with more than one publication describing results among the same or overlapping groups of patients or controls the largest of the available published data sets was included to avoid double counting. For studies with more than one control group, the most appropriate control group was used. Where neither control group was methodologically superior the largest was used.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Robins1">[14]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Mantel1">[15]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-DerSimonian1">[16]</xref>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Deek1">[17]</xref>
###xml 1118 1122 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Egger1">[18]</xref>
Data were analyzed using software for preparing and maintaining Cochrane reviews (Review Manager v4.2.8, Cochrane Collaboration, ) and Comprehensive Meta Analysis v2.2.023 (Biostat, ). To determine the strength of genetic association a pooled odds ratio (OR) was calculated for each gene variant using fixed- and random-effects models, in addition to the calculation of 95% confidence intervals (CI). Fixed-effects summary ORs were calculated using the Mantel-Haenszel method,[14], [15] and the DerSimonian and Laird method was used to calculate random-effects summary ORs [16]. The results were very similar for both summary OR so only one is presented. The frequency of at-risk genotypes was compared between cases and controls for each single nucleotide polymorphism (SNP) analyzed. For each meta-analysis, the I2 was calculated and a chi-squared test for heterogeneity was performed.[17] The genetic models used reflected those evaluated in the primary publication. For assessment of small-study bias, funnel plots and the Egger regression asymmetry test were conducted for each SNP with four or more publications.[18]
###end p 23
###begin p 24
The proportion of haemorrhagic stroke cases in the population that could be attributed to a particular gene variant (population-attributable risk [PAR]) was estimated as follows:For this calculation the fixed effects model was used and the prevalence of exposure was estimated as the genotype frequency among control adults.
###end p 24
###begin title 25
Results
###end title 25
###begin p 26
###xml 297 305 297 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g001">Figure 1</xref>
Our initial search identified 1,565 studies of which 85 met our inclusion criteria. In total, 40 polymorphisms in 27 genes were identified. Genes with three or more publications on each SNP were included in our analyses, leaving a total of 55 publications addressing 13 polymorphisms in 12 genes (Figure 1).
###end p 26
###begin title 27
Flow chart illustrating number of studies included in the meta-analyses.
###end title 27
###begin p 28
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003691-t001">Table 1</xref>
###xml 224 235 <span type="species:ncbi:9606">participant</span>
From the 12 genes analysed in detail (representing 6,367 cases and 13,504 controls), the mean number of studies per candidate gene was five. Six (46%) of the 13 meta-analyses had more than 500 cases, and 8 (62%) had a total participant size of greater than 1000 (Table 1). No single meta-analysis had more than 2000 cases.
###end p 28
###begin title 29
Details of size of studies included in each gene investigated.
###end title 29
###begin p 30
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003691-t002">Table 2</xref>
Table 2 shows the genotypic odds ratios (ORs) for the 13 polymorphisms evaluated.
###end p 30
###begin title 31
Summary data of candidate genes in haemorrhagic stroke.
###end title 31
###begin p 32
Apo epsilon2 (bold) vs others.
###end p 32
###begin p 33
Apo epsilon4 (bold) vs others.
###end p 33
###begin p 34
Abbreviations: OR, fixed effect odds ratio; P Het, P value for heterogeneity; ACE, gene encoding angiotensin converting enzyme; eNOS, gene encoding endothelial nitric oxide synthase; MTHFR, gene encoding methylenetetrahydrofolate reductase; I/D, insertion/deletion; VNTR, variable number tandem repeat; All HS, all haemorrhagic stroke; ICH, intracerebral haemorrhage; SAH, subarachnoid haemorrhage; CAAH, cerebral amyloid angiopathy-related haemorrhage.
###end p 34
###begin p 35
Table shows both alleles with the one used for analysis in bold followed by the genetic model used for genotype characterisation. Apo epsilon2 (bold) vs others. Apo epsilon4 (bold) vs others.
###end p 35
###begin title 36
Apolipoprotein E:
###end title 36
###begin p 37
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Yi1">[19]</xref>
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Catto1">[29]</xref>
###xml 450 459 354 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2a</xref>
###xml 561 570 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2b</xref>
###xml 700 701 596 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 710 711 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 711 714 607 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 729 730 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 739 740 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 740 743 634 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
The most investigated gene was apolipoprotein E, with 11 studies [19]-[29] that included 1376 cases and 3531 controls. APOE epsilon2, epsilon3 and epsilon4 alleles were analysed in a dominant model (i.e. epsilon2epsilon4+epsilon3epsilon4+epsilon4epsilon4 vs all other genotypes or epsilon2epsilon2+epsilon2epsilon3+epsilon2epsilon4 vs all other genotypes). For intracerebral haemorrhage, no association was found for carriers of the epsilon2 allele (Figure 2a) (OR, 1.09; 95% CI, 0.88-1.35), but an association was observed for carriers of the epsilon4 allele (Figure 2b) with an OR of 1.17 (95% CI, 0.98-1.40; P = 0.08). No significant interstudy OR heterogeneity was observed for either allele (chi2 = 9.54; PHet = 0.30 and chi2 = 7.48; PHet = 0.49 respectively).
###end p 37
###begin p 38
###xml 1269 1276 1269 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
2a. Results for apolipoprotein &b.epsi;2 allele and intracerebral haemorrhage comparing carriers of the &b.epsi;2 allele with those with the &b.epsi;3 and &b.epsi;4 alleles. 2b. Results for apolipoprotein &b.epsi;4 allele and intracerebral haemorrhage comparing carriers of the &b.epsi;4 allele with those with the &b.epsi;2 and &b.epsi;3 alleles. 2c. Results for apolipoprotein &b.epsi;2 allele and subarachnoid haemorrhage comparing carriers of the &b.epsi;2 allele with those with the &b.epsi;3 and &b.epsi;4 alleles. 2d. Results for apolipoprotein &b.epsi;4 allele and subarachnoid haemorrhage comparing carriers of the &b.epsi;4 allele with those with the &b.epsi;2 and &b.epsi;3 alleles. 2e. Results for apolipoprotein &b.epsi;2 allele and cerebral amyloid angiopathy-related haemorrhage comparing carriers of the &b.epsi;2 allele with those with the &b.epsi;3 and &b.epsi;4 alleles. 2f. Results for apolipoprotein &b.epsi;4 allele and cerebral amyloid angiopathy-related haemorrhage comparing carriers of the &b.epsi;4 allele with those with the &b.epsi;2 and &b.epsi;3 alleles. 2g. Results for apolipoprotein &b.epsi;2 allele and lobar or non-lobar haemorrhage comparing carriers of the &b.epsi;2 allele with those with the &b.epsi;3 and &b.epsi;4 alleles. 2h. Results for apolipoprotein &b.epsi;4 allele and lobar or non-lobar haemorrhage comparing carriers of the &b.epsi;4 allele with those with the &b.epsi;2 and &b.epsi;3 alleles.
###end p 38
###begin p 39
###xml 85 94 79 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2c</xref>
###xml 109 118 97 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2d</xref>
For subarachnoid haemorrhage, no association was found for carriers of the epsilon2 (Figure 2c) or epsilon4 (Figure 2d) allele with ORs of 1.20 (95% CI, 0.85-1.70; p = 0.30) and 1.22 (95% CI, 0.90-1.64; p = 0.19), respectively. No significant interstudy OR heterogeneity was observed for either allele.
###end p 39
###begin p 40
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-McCarron1">[23]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Garcia1">[25]</xref>
###xml 398 407 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2e</xref>
###xml 484 493 472 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figure 2f</xref>
###xml 603 604 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 613 614 593 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 614 617 594 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 642 643 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 652 653 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 653 656 625 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
Only two publications (64 cases and 430 controls) with genotype frequencies addressed cerebral amyloid angiopathy-related haemorrhage. McCarron et al. [23] used histology to confirm a diagnosis of CAAH, while Garcia et al. [25] used neuroimaging and clinical criteria to diagnose 'probable/possible' CAAH. Carriers of the epsilon2 allele demonstrated an OR of 3.36 (95% CI, 1.71-6.59; p = 0.0004) (Figure 2e) and for carriers of epsilon4 an OR of 2.69 (95% CI, 1.47-4.92; p = 0.001) (Figure 2f) for this condition. No significant interstudy OR heterogeneity was observed for either allele (epsilon2: chi2 = 0.78; PHet = 0.36 and epsilon4: chi2 = 0.55; PHet = 0.45).
###end p 40
###begin p 41
###xml 174 178 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Sudlow1">[30]</xref>
###xml 192 196 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Woo1">[20]</xref>
###xml 198 202 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Seifert1">[22]</xref>
###xml 204 208 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-McCarron1">[23]</xref>
###xml 210 214 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Garcia1">[25]</xref>
###xml 582 599 558 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g002">Figures 2g and 2h</xref>
###xml 696 697 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 706 707 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 707 710 675 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 742 743 702 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 752 753 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 753 756 713 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 784 785 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 794 795 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 795 798 747 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 830 831 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 840 841 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 841 844 785 788 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
Previous studies investigating apolipoprotein E in haemorrhagic stroke have addressed the association of the epsilon2 and epsilon4 alleles in lobar and non-lobar haemorrhage.[30] Four studies [20], [22], [23], [25] provided data that appropriately categorized haemorrhage location as lobar or non-lobar. Both epsilon2 and epsilon4 alleles were significantly associated with lobar haemorrhage (OR, 1.81; 95% CI, 1.26-2.62; P = 0.002 and OR, 1.49; 95% 1.08-2.05; P = 0.01 respectively) but not with non-lobar haemorrhage (OR, 1.08; 95% CI, 0.80-1.47 and OR, 1.05; 95% CI, 0.81-1.37) (Figures 2g and 2h). No significant interstudy OR heterogeneity was observed for either allele (epsilon2 lobar: chi2 = 6.91; PHet = 0.07; epsilon2 non-lobar: chi2 = 2.01; PHet = 0.57; epsilon4 lobar: chi2 = 3.20; PHet = 0.36; epsilon4 non-lobar: chi2 = 2.88; PHet = 0.41).
###end p 41
###begin title 42
SERPINE1:
###end title 42
###begin p 43
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Zhang1">[31]</xref>
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Catto2">[35]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Reiner1">[33]</xref>
###xml 410 412 410 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5G</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 470 478 470 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g003">Figure 3</xref>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 739 740 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 749 750 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 750 753 748 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 911 912 909 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A total of five studies [31]-[35] (240 cases and 1233controls) investigated the SERPINE1 (also known as plasminogen activator inhibitor-1) 4G/5G polymorphism. Four addressed intracerebral haemorrhage and one study [33] addressed intracerebral haemorrhage, subarachnoid haemorrhage and ruptured intracranial aneurysm. For intracerebral haemorrhage alone an association was observed for those homozygous for the 5G allele with an OR of 1.40 (95% CI, 0.98-2.00; P = 0.07) (Figure 3). When subarachnoid haemorrhage and ruptured intracranial aneurysm cases were included in this analysis a significant association was observed with a similar OR of 1.42 (95% CI, 1.03-1.96; P = 0.03). No significant interstudy OR heterogeneity was observed (chi2 = 0.28; PHet = 0.99). The distribution of the OR in relation to its standard deviation in the funnel plot was symmetrical, and the Egger test result was not significant (P = 0.178), suggesting a low probability of small-study bias.
###end p 43
###begin title 44
###xml 60 62 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5G</italic>
Results for SERPINE1 4G/5G and intracerebral haemorrhage of 5G allele homozygous (5G/5G) genotype.
###end title 44
###begin title 45
Angiotensin-Converting Enzyme:
###end title 45
###begin p 46
###xml 21 25 21 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Slowik1">[36]</xref>
###xml 26 30 26 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Dikmen1">[43]</xref>
A total of 8 studies [36]-[43] (744 cases and 1289 controls) were identified that evaluated the ACE/ID polymorphism of which five related to intracerebral haemorrhage, one for subarachnoid haemorrhage and two for ruptured intracranial aneurysm.
###end p 46
###begin p 47
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 638 646 638 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g004">Figure 4</xref>
###xml 706 707 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 717 718 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 718 721 716 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 1250 1251 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
No significant association for haemorrhagic stroke was found for those homozygous for the D allele (ACE/DD) for intracerebral haemorrhage alone (OR, 1.00; 95% CI, 0.73-1.36; p = 1.00), or with subarachnoid haemorrhage or ruptured intracranial aneurysm (OR, 0.87; 95% CI, 0.65-1.14; p = 0.09). In addition to examining the association of the ACE/DD genotype with haemorrhagic stroke, several studies have suggested that the ACE/II genotype may be associated with haemorrhagic stroke. When all studies were evaluated together, those homozygous for the ACE/I allele demonstrated an overall pooled OR of 1.48 (95% CI, 1.20-1.83; p = 0.0003) (Figure 4). Significant interstudy OR heterogeneity was observed (chi2 = 16.69; PHet = 0.02), however a random-effect model that takes into account the intra- and inter-study variability resulted in a similar overall estimate that remained significant (OR, 1.45; 95% CI, 1.01-2.07; p = 0.04). The distribution of the OR in relation to its standard deviation in the funnel plot was symmetrical, and the Egger test result was not significant (p = 0.667), suggesting a low probability of small-study bias. For intracerebral haemorrhage alone this association did not remain significant (OR, 1.27; 95% CI, 0.90-1.77; P = 0.17). However, for subarachnoid haemorrhage or ruptured intracranial aneurysm, a summary OR, under a fixed-effect model, of 1.64 (95% CI, 1.24-2.17; p = 0.0003) was observed.
###end p 47
###begin title 48
Results for ACE/II gene and haemorrhagic stroke.
###end title 48
###begin title 49
Factor V:
###end title 49
###begin p 50
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Catto4">[44]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Longstreth1">[45]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Corral1">[46]</xref>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adenine</italic>
###xml 417 432 417 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">guanine/guanine</italic>
###xml 435 444 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g005">Figure 5a</xref>
###xml 504 505 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 514 515 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 515 518 513 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
Three studies (285 cases, 836 controls) investigated haemorrhagic stroke in the factor V Leiden mutation. One addressed intracerebral haemorrhage [44] and two addressed both intracerebral haemorrhage and subarachnoid haemorrhage [45], [46]. When considered in totality, carriers of the adenine allele were less likely to develop haemorrhagic stroke (OR, 0.31; 95% CI, 0.11-0.90; p = 0.03) when compared to wild-type (guanine/guanine) (Figure 5a). No significant interstudy heterogeneity was observed (chi2 = 0.74; PHet = 0.69)
###end p 50
###begin p 51
5a. Results for Factor V Leiden mutation and haemorrhagic stroke. 5b. Results for Factor V Leiden mutation and ICH. 5c. Results for Factor V Leiden mutation and SAH.
###end p 51
###begin p 52
###xml 165 174 165 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g005">Figure 5b</xref>
###xml 307 316 307 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g005">Figure 5c</xref>
###xml 394 395 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 404 405 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 405 408 403 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 449 450 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 459 460 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 460 463 456 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
For intracerebral haemorrhage alone, a summary OR, under the fixed-effects model, of 0.29 (95% CI, 0.08-1.05; p = 0.06) was observed for adenine allele homozygotes (Figure 5b). For subarachnoid haemorrhage alone, a summary OR, under a fixed-effect model, of 0.45 (95% CI, 0.11-1.95; p = 0.29) was observed (Figure 5c). No significant interstudy heterogeneity was observed for intracerebral (chi2 = 1.38; PHet = 0.50) or subarachnoid haemorrhage (chi2 = 0.26; PHet = 0.61).
###end p 52
###begin title 53
Endoglin:
###end title 53
###begin p 54
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Alberts2">[47]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Peters1">[48]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Pera1">[49]</xref>
###xml 310 319 310 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">insertion</italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 446 447 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 456 457 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 457 460 455 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
Three studies (285 cases; 512 controls) investigated risk of haemorrhagic stroke and the exon 7/8 GA insertion of the gene encoding endoglin. One study addressed intracerebral haemorrhage [47] and two studies addressed subarachnoid haemorrhage [48], [49]. When considered in totality, those homozygous for the insertion allele demonstrated an OR of 3.47 (95% CI, 1.45-8.30; p = 0.005). No significant interstudy OR heterogeneity was observed (chi2 = 1.15; PHet = 0.56).
###end p 54
###begin title 55
SERPINA3:
###end title 55
###begin p 56
###xml 21 25 21 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Krischek1">[50]</xref>
###xml 26 30 26 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Fu1">[55]</xref>
A total of 6 studies [50]-[55] (1069 cases and 1294 controls) were identified that evaluated the polymorphism in the gene encoding SERPINA3 (also known as alpha1-antichymotrypsin) where alanine is replaced by threonine. Four of these addressed intracerebral haemorrhage and two addressed subarachnoid haemorrhage.
###end p 56
###begin p 57
###xml 342 350 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g006">Figure 6</xref>
###xml 410 411 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 420 421 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 421 424 419 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 516 517 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For intracerebral haemorrhage, a summary OR, under the fixed-effects model, of 1.28 (95% CI, 0.98-1.67; p = 0.07) was observed for individuals homozygous for the T allele compared with A allele carriers (AT+AA). For subarachnoid haemorrhage alone, a summary OR, under a fixed-effect model, of 0.94 (95% CI, 0.71-1.24; p = 0.65) was observed (Figure 6). No significant interstudy heterogeneity was observed (chi2 = 5.17; PHet = 0.40) and the funnel plot distribution was symmetrical with an insignificant Egger test (P = 0.14), indicating a low probability of small-study bias.
###end p 57
###begin title 58
Results for SERPINA3/TT in haemorrhagic stroke.
###end title 58
###begin title 59
Endothelial nitric oxide synthase:
###end title 59
###begin p 60
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 13 14 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Song1">[56]</xref>
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Akagawa1">[59]</xref>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g007">Figure 7</xref>
###xml 359 360 357 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 369 370 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 370 373 368 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
The eNOS T786C mutation was evaluated in 4 studies [56]-[59], all of which addressed subarachnoid haemorrhage with a total of 893 cases and 784 controls. The summary OR under a fixed-effect model showed an OR for dominant carriers of the 786C mutation of 1.27 (95% CI, 0.99-1.62; P = 0.06) (Figure 7). No significant interstudy heterogeneity was observed (chi2 = 1.76; PHet = 0.62). The distribution of the ORs from individual studies in relation to their respective standard deviations was symmetrical, and the Egger test result suggested a low probability of small-study bias (p = 0.29).
###end p 60
###begin title 61
Results for eNOS/786C polymorphism and subarachnoid haemorrhage.
###end title 61
###begin title 62
Methylenetetrahydrofolate reductase:
###end title 62
###begin p 63
###xml 13 17 13 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Sazci1">[60]</xref>
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Dikmen2">[64]</xref>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">677</sup>
###xml 253 261 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003691-g008">Figure 8</xref>
###xml 321 322 319 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 331 332 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 332 335 330 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
Five studies [60]-[64] investigated the MTHFR C677T polymorphism, all addressing intracerebral haemorrhage (635 cases; 2275 controls). No significant association for intracerebral haemorrhage was found for 677TT (OR, 1.11; 95% CI, 0.89-1.39; p = 0.35) (Figure 8). No significant interstudy heterogeneity was observed (chi2 = 7.29; PHet = 0.12) and the funnel plot distribution was symmetrical with an insignificant Egger test (p = 0.27), indicating a low probability of small-study bias.
###end p 63
###begin title 64
Results for MTHFR/677TT gene and intracerebral haemorrhage.
###end title 64
###begin title 65
Factor XIII:
###end title 65
###begin p 66
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Reiner1">[33]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Slowik4">[65]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Corral2">[68]</xref>
###xml 277 284 277 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">leucine</italic>
###xml 488 489 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 498 499 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 499 502 497 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Het</sub>
###xml 813 820 811 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">leucine</italic>
###xml 842 848 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">valine</italic>
###xml 866 869 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V/L</italic>
###xml 875 878 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V/V</italic>
The factor XIII valine/leucine polymorphism was investigated in 5 studies [33], [65]-[68]. Subarachnoid haemorrhage was addressed in addition to intracerebral haemorrhage in two of these studies (531 cases; 1172 controls). When considered in totality, those homozygous for the leucine allele demonstrated an OR of 1.39 for haemorrhagic stroke (95% CI, 0.89-2.08), although this result was not statistically significant (p = 0.15). No significant interstudy heterogeneity was observed (chi2 = 7.45; PHet = 0.11) and the funnel plot distribution was symmetrical with an nonsignificant Egger test (p = 0.27), indicating a low probability of small-study bias. For intracerebral haemorrhage, a summary OR under a fixed-effect model of 1.32 (95% CI, 0.82-2.06; p = 0.27) was observed for individuals homozygous for the leucine allele compared with valine allele carriers (V/L plus V/V)).
###end p 66
###begin title 67
Glycoprotein Ib-alpha:
###end title 67
###begin p 68
###xml 135 139 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Iniesta1">[69]</xref>
###xml 141 145 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Carter1">[70]</xref>
###xml 215 219 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Iniesta2">[71]</xref>
Three studies investigated haemorrhagic stroke in the glycoprotein 1b-alpha VNTR polymorphism. Two addressed intracerebral haemorrhage [69], [70] (198 cases; 563 controls) and one addressed subarachnoid haemorrhage [71] (103 cases; 103 controls). When considered in totality carriers of the B group of tandem repeats had no associated risk for haemorrhagic stroke with a summary OR, under a fixed-effect model, of 1.04 (95% CI, 0.66-1.64; p = 0.85).
###end p 68
###begin title 69
Glycoprotein Ia and IIIa:
###end title 69
###begin p 70
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Iniesta1">[69]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Iniesta2">[71]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Reiner2">[72]</xref>
Three studies investigated haemorrhagic stroke in the glycoprotein Ia Glu505Lys polymorphism [69], [71], [72] (286 cases; 590 controls). No association for haemorrhagic stroke was found for carriers of the lysine allele with a summary OR, under the fixed-effect model, of 0.82 (95% CI, 0.56-1.20). Additionally, the same studies found no association for haemorrhagic stroke with the C807T polymorphism of glycoprotein Ia (OR, 1.15; 95% CI, 0.83-1.59) nor for the glycoprotein IIIa Leu33Pro polymorphism (OR, 0.76; 95% CI, 0.54-1.07).
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 560 563 560 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Casas1">[6]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Wald1">[73]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Keavney1">[74]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Lindqvist1">[75]</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Donahue1">[76]</xref>
###xml 157 169 <span type="species:ncbi:9606">participants</span>
In this comprehensive meta-analysis, four of the 13 (31%) polymorphisms analyzed significantly increased the risk of haemorrhagic stroke. The mean number of participants in two of these meta-analyses (ACE and SERPINE1) was more than 1850, allowing more precise estimates to be made of the effect of these genes than from any single study. The individual risk provided by these candidate genes was moderate (OR, 1.48; 95% CI: 1.20-1.83 and 1.42, 95% CI: 1.03-1.96, respectively). This effect size is in broad agreement with previous studies in ischaemic stroke [6] and other complex diseases that are thought to have a polygenic basis, such as ischaemic heart disease [73], [74]. Further, our study suggests that the hypercoagulable state conferred by the factor V Leiden mutation is protective against haemorrhagic stroke (OR, 0.31; 95% CI, 0.11-0.90; p = 0.03). This is in accordance with previous studies that have suggested a protective role for this polymorphism in other bleeding disorders. [75], [76] However, these results are based on a smaller dataset compared to ischaemic stroke making the point estimates less reliable. The seven gene variants in the six remaining genes - factor XIII, MTHFR, SERPINA3 and glycoproteins Ia, 1b-alpha, and IIIa - have so far failed to provide evidence to support an increased susceptibility to haemorrhagic stroke.
###end p 72
###begin p 73
###xml 479 483 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-McCarron2">[77]</xref>
###xml 484 488 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Nicoll1">[79]</xref>
The majority of candidate genes in haemorrhagic stroke have been investigated initially for their potential role in ischaemic stroke. For APOE, our results are in accordance with previous histological studies suggesting that, while the epsilon4 allele enhances the deposition of amyloid-beta in peripheral (lobar) cerebral vasculature, the epsilon2 allele predisposes to the rupture of these lobar amyloid-beta laden vessels, possibly through the promotion of fibrinoid necrosis [77]-[79]
###end p 73
###begin p 74
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003691-t003">Table 3</xref>
###xml 544 551 544 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003691-t003">Table 3</xref>
A meta-analysis of genetic studies in ischaemic stroke by our group in 2004 investigated, among others, 9 (75%) of the 12 candidate genes in our study (Table 3) and involved approximately 3 times as many cases and controls. Although ischaemic and haemorrhagic stroke may share some common risk factors they are thought to have quite distinct molecular pathogeneses. Our current work demonstrates strikingly similar genetic ORs between the two major pathologies supporting a similar aetiological role for both ischaemic and haemorrhagic stroke (Table 3) with a greater patho-aetiological similarity existing between small vessel ischaemic disease and deep cerebral haemorrhage. Interestingly, Factor V was associated with ischaemic stroke and protective for haemorrhagic stroke, providing a biological relevant and important role for its aetiology in cerebrovascular disease.
###end p 74
###begin title 75
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">104</sup>
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">97</sup>
Odds ratios and 95% CIs of gene variants investigated in both ischaemic and haemorrhagic stroke. Data taken from Casas et al.104 and Ariyaratnam et al.97
###end title 75
###begin p 76
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4G/5G</italic>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Brott1">[80]</xref>
The population-attributable risks (PARs) for gene variants with the most reliable associations for haemorrhagic stroke in this study were 9.24% for the ACE/ID polymorphism and 7.78% for the SERPINE1 4G/5G. These values are lower than those reported for well-established risk factors for haemorrhagic stroke, such as hypertension [80] but not surprising, because the genetic contribution of any single gene toward a complex disease is unlikely to act in a simple mendelian fashion but rather with epistatic (gene-gene or gene-environmental interaction) effects. Nevertheless, given the high incidence of haemorrhagic stroke (100,000 per year in the United States), if these estimates hold true they suggest that common variants in the ACE and SERPINE1 genes alone may contribute between 8,000-10,000 haemorrhagic strokes in the United States each year.
###end p 76
###begin p 77
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Yi1">[19]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Fu1">[55]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Zhang2">[81]</xref>
###xml 824 831 824 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 838 845 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 857 860 845 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/T</italic>
###xml 867 872 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T786C</italic>
###xml 888 893 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C677T</italic>
###xml 907 914 895 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Val/Leu</italic>
###xml 928 933 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4G/5G</italic>
###xml 1173 1176 1161 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Ariyaratnam1">[5]</xref>
###xml 1178 1181 1166 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Casas1">[6]</xref>
###xml 1354 1366 <span type="species:ncbi:9606">participants</span>
###xml 1444 1452 <span type="species:ncbi:9606">patients</span>
The interpretation of any meta-analysis must be made within the context of its limitations, including study selection, publication bias, and variability in the methodological quality of the included studies. A comprehensive search was undertaken for all relevant studies including non-English language [19], [55], [81]. Although publication bias can never be completely excluded, many of the individual studies included in our meta-analyses were not statistically significant and were interpreted by their authors as negative studies suggesting a desire by authors to submit, and a willingness by editors to publish such work. In addition, Egger asymmetry tests and funnel plots showed no substantial evidence of publication bias in the nine meta-analyses for which four or more studies had been published (apolipoprotein E epsilon4, and epsilon2; SERPINA3 A/T; eNOS T786C; ACE/ID; MTHFR C677T; factor XIII Val/Leu and SERPINE1 4G/5G), although it is acknowledged that at times the study numbers for each gene were small as was the number of subjects for each study making the point estimates less reliable when compared against our previous larger meta-analyses in stroke [5], [6]. Moreover, rigorous selection criteria (use of neuroimaging or autopsy to diagnose haemorrhagic stroke) enriched the meta-analyses for studies with comparable selection of participants and haemorrhagic stroke sub-types. Notwithstanding these selection criteria, patients with severe ICH from any aetiology who died at onset without gaining access to secondary care could not have entered in any of the included manuscripts.
###end p 77
###begin p 78
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Dichgans2">[82]</xref>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1556 1560 1556 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Hoggart1">[83]</xref>
###xml 1800 1804 1800 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Wellcome1">[84]</xref>
###xml 1248 1256 <span type="species:ncbi:9606">patients</span>
Only two of our meta-analyses included more than 1000 cases (apolipoprotein E and SERPINA3). Reliable interpretation of the association of candidate genes with haemorrhagic stroke will only come from studies with an order of magnitude larger than those performed to date. Dichgans et al.[82] suggest that to confirm odds ratios between 1.2-1.5 in candidate genes with allele frequencies between 0.1-0.5, sample sizes of 800-20,000 are required to achieve reliable statistical significance at a P value of at least 0.05. The average number of cases and controls in our meta-analysis were just 578 and 1224 respectively. Achieving appropriate sample sizes is only likely to be achieved using a multicenter collaborative approach, with studies using uniform criteria for the selection of cases and controls and submitting both positive and negative data to a common database for continuously updated and cumulative meta-analysis. Using neuroimaging- or autopsy-diagnosed haemorrhagic stroke as a selection criteria may have helped to maintain comparable groups of cases. However the selection of control groups varied considerably between studies with some excluding control subjects with established hypertension, while others argued that as not all patients with haemorrhagic stroke have high blood pressure such exclusion of control population is unnecessary. Statistical methods using marker genotype data may in the future permit the detection and control of confounding due to population stratification and selection bias in genetic association studies.[83] This may reduce the impact of variability within controls groups, although the strategy of using a control group that has not been specifically phenotyped for comparison with each individual disease has recently been successfully employed [84] suggesting that this is not a major problem.
###end p 78
###begin p 79
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Broderick1">[85]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Qureshi1">[86]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Suzuki1">[87]</xref>
###xml 699 702 699 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Ariyaratnam1">[5]</xref>
All studies from different ancestral backgrounds were included. Although there is evidence to suggest that allele frequencies for several candidate genes investigated in our study vary between ethnicity, and epidemiological studies suggest differences in the incidence and prevalence of haemorrhagic stroke in certain ethnic groups with the rate in black Americans twice that of white Americans,[85], [86] as well as a greater incidence in Japanese population when compared to Caucasian populations [87], the majority of our studies were conducted in Caucasians. Indeed, we have recently shown in ischaemic stroke that differences in genetic effects across different ethnic groups may be overstated [5]. However, the effect of heterogeneity by ethnicity cannot be completely dismissed.
###end p 79
###begin p 80
###xml 1057 1065 <span type="species:ncbi:9606">patients</span>
Only adults with ruptured intracranial aneurysm were included in our analyses addressing subarachnoid haemorrhage. Many published articles have investigated genetic polymorphisms in subjects with unruptured intracranial aneurysm. While some genes may predispose to the formation of intracranial aneurysms, others may predispose to rupture of aneurysms. By performing a similar meta-analysis of genetic association studies in unruptured intracranial aneurysm it may be possible to further our understanding of the genetic and molecular pathogenesis of subarachnoid haemorrhage. Although attempts were made to analyse sub-types of haemorrhage separately, the majority of the time such data were not readily available. For this, as well as reasons of aetiology where it can be argued that haemorrhagic stroke at its most basic consists of vessel rupture, data were combined. Readers should therefore assess this manuscript with this limitation in mind. Further, even within the category of primary intracerebral haemorrhage, heterogeneity may exist while some patients may not have been subjected to detailed investigations in order to determine secondary underlying causes, thus erroneously labelling them clinically as 'primary'.
###end p 80
###begin p 81
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Yamada1">[88]</xref>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003691-Yang1">[89]</xref>
Although it is not possible to exclude the future identification of one or more genes with a more substantial effect on risk of haemorrhagic stroke using different models such as genome wide association searches, our findings based upon candidate gene strategies suggest that several genes, each with a small to moderate effect, are likely to act individually, together, or in combination with environmental determinants to contribute towards haemorrhagic stroke. One implication of these findings is that predictive genetic tests that use any single variant are unlikely individually to have much value. However, tests that combine genotyping for one or more risk alleles and that integrate the results with established risk prediction tools based on acquired risk factors may have greater utility.[88], [89]
###end p 81
###begin p 82
This study may have important implications for those involved in exploring the genetic aetiology of blood pressure because of the relationship between haemorrhagic stroke and hypertension. Few studies (approximately50%) reported the prevalence of hypertension among their case and control populations. Of those that did the average incidence of hypertension among cases in the ACE study was 51.7% compared to 29.7% in controls, and for PAI-1 the average for cases was 26.7% and for controls 12.9%. From our study the mechanism by which causative SNPs lead to haemorrhagic stroke cannot be certain, although this could be via known causal pathways such as hypertension especially if those genes are involved in blood pressure regulation. There is, therefore, a clear need for future investigators and editors to ensure that this important variable is documented and published in the final manuscripts.
###end p 82
###begin p 83
In summary, this study suggests the existence of a genetic basis for some types of haemorrhagic stroke with no single gene but rather demonstrates a polygenic aetiology. However, the evidence base is smaller than when compared against ischaemic stroke, although the odds ratios are of similar magnitude. An international collaborative approach is more likely to lead to a sufficient number of subjects being recruited for the reliable identification of risk alleles in haemorrhagic stroke.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
Geographic variations in stroke incidence and mortality among older populations in four US communities.
###end article-title 85
###begin article-title 86
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.
###end article-title 86
###begin article-title 87
Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.
###end article-title 87
###begin article-title 88
Primary intracerebral hemorrhage.
###end article-title 88
###begin article-title 89
###xml 35 42 <span type="species:ncbi:9606">persons</span>
Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals.
###end article-title 89
###begin article-title 90
Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.
###end article-title 90
###begin article-title 91
Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina.
###end article-title 91
###begin article-title 92
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage.
###end article-title 92
###begin article-title 93
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark.
###end article-title 93
###begin article-title 94
Familial aneurysmal subarachnoid hemorrhage: a community-based study.
###end article-title 94
###begin article-title 95
Familial intracranial aneurysms.
###end article-title 95
###begin article-title 96
Genetic association studies in stroke: methodological issues and proposed standard criteria.
###end article-title 96
###begin article-title 97
###xml 38 43 <span type="species:ncbi:9606">human</span>
A road map for efficient and reliable human genome epidemiology.
###end article-title 97
###begin article-title 98
A general estimator for the variance of the Mantel-Haenszel odds ratio.
###end article-title 98
###begin article-title 99
Statistical aspects of the analysis of data from retrospective studies of disease.
###end article-title 99
###begin article-title 100
Meta-analysis in clinical trials.
###end article-title 100
###begin article-title 101
Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis.
###end article-title 101
###begin article-title 102
Bias in meta-analysis detected by a simple, graphical test.
###end article-title 102
###begin article-title 103
Apolipoprotein E Polymorphism in Ischemic and Hemorrhagic Stroke.
###end article-title 103
###begin article-title 104
Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage.
###end article-title 104
###begin article-title 105
Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage.
###end article-title 105
###begin article-title 106
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population.
###end article-title 106
###begin article-title 107
###xml 68 76 <span type="species:ncbi:9606">patients</span>
High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.
###end article-title 107
###begin article-title 108
Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.
###end article-title 108
###begin article-title 109
Cerebral hemorrhage and apoE.
###end article-title 109
###begin article-title 110
Lack of association between the apolipoprotein E gene and aneurysmal subarachnoid hemorrhage in an Italian population.
###end article-title 110
###begin article-title 111
###xml 70 76 <span type="species:ncbi:9103">Turkey</span>
Apolipoprotein E polymorphism and stroke in a population from eastern Turkey.
###end article-title 111
###begin article-title 112
Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study.
###end article-title 112
###begin article-title 113
Apolipoprotein E polymorphism in cerebrovascular disease.
###end article-title 113
###begin article-title 114
Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls.
###end article-title 114
###begin article-title 115
[The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease].
###end article-title 115
###begin article-title 116
Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
###end article-title 116
###begin article-title 117
###xml 106 111 <span type="species:ncbi:9606">women</span>
Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women.
###end article-title 117
###begin article-title 118
###xml 119 124 <span type="species:ncbi:9606">women</span>
The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women.
###end article-title 118
###begin article-title 119
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.
###end article-title 119
###begin article-title 120
II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm.
###end article-title 120
###begin article-title 121
DD genotype of ACE gene is a risk factor for intracerebral hemorrhage.
###end article-title 121
###begin article-title 122
Lack of an association between the angiotensin-converting enzyme insertion/deletion polymorphism and intracranial aneurysms in a Caucasian population in the United States.
###end article-title 122
###begin article-title 123
Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease.
###end article-title 123
###begin article-title 124
Lack of association between angiotensin I-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese.
###end article-title 124
###begin article-title 125
The ACE I allele is associated with increased risk for ruptured intracranial aneurysms.
###end article-title 125
###begin article-title 126
Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease.
###end article-title 126
###begin article-title 127
Are the angiotensin-converting enzyme gene and activity risk factors for stroke?
###end article-title 127
###begin article-title 128
Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke.
###end article-title 128
###begin article-title 129
###xml 24 29 <span type="species:ncbi:9606">women</span>
Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A).
###end article-title 129
###begin article-title 130
Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.
###end article-title 130
###begin article-title 131
Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage.
###end article-title 131
###begin article-title 132
A DNA sequence polymorphism in the endoglin gene is not associated with intracranial aneurysm or aneurysmal subarachnoid hemorrhage.
###end article-title 132
###begin article-title 133
Endoglin gene insertion polymorphism not associated with aneurysmal subarachnoid hemorrhage.
###end article-title 133
###begin article-title 134
The alanine/threonine polymorphism of the alpha-1-antichymotrypsin (SERPINA3) gene and ruptured intracranial aneurysms in the Japanese population.
###end article-title 134
###begin article-title 135
Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage.
###end article-title 135
###begin article-title 136
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Alpha(1)-antichymotrypsin gene polymorphism in patients with stroke.
###end article-title 136
###begin article-title 137
SERPINA3 polymorphism is not associated with primary intracerebral hemorrhage in a Polish population.
###end article-title 137
###begin article-title 138
Alpha(1)-antichymotrypsin polymorphism: a risk factor for hemorrhagic stroke in normotensive subjects.
###end article-title 138
###begin article-title 139
[Association between alpha-1-antichymotrypsin gene polymorphism and cerebral hemorrhage].
###end article-title 139
###begin article-title 140
Endothelial nitric oxide gene T-786C polymorphism and subarachnoid hemorrhage in Korean population.
###end article-title 140
###begin article-title 141
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Using endothelial nitric oxide synthase gene polymorphisms to identify intracranial aneurysms more prone to rupture in Japanese patients.
###end article-title 141
###begin article-title 142
The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture.
###end article-title 142
###begin article-title 143
Influence of endothelial nitric oxide synthase T-786C single nucleotide polymorphism on aneurysm size.
###end article-title 143
###begin article-title 144
Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C.
###end article-title 144
###begin article-title 145
Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease.
###end article-title 145
###begin article-title 146
Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China.
###end article-title 146
###begin article-title 147
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Methylenetetrahydrofolate reductase gene polymorphisms in patients with cerebral hemorrhage.
###end article-title 147
###begin article-title 148
Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms.
###end article-title 148
###begin article-title 149
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
###end article-title 149
###begin article-title 150
A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
###end article-title 150
###begin article-title 151
Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?
###end article-title 151
###begin article-title 152
Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage.
###end article-title 152
###begin article-title 153
Polymorphisms of platelet adhesive receptors: do they play a role in primary intracerebral hemorrhage?
###end article-title 153
###begin article-title 154
Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.
###end article-title 154
###begin article-title 155
Platelet GP IIIa polymorphism HPA-1 (PlA) protects against subarachnoid hemorrhage.
###end article-title 155
###begin article-title 156
###xml 80 85 <span type="species:ncbi:9606">women</span>
Genetic variants of platelet glycoprotein receptors and risk of stroke in young women.
###end article-title 156
###begin article-title 157
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
###end article-title 157
###begin article-title 158
Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators.
###end article-title 158
###begin article-title 159
Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss-a possible evolutionary selection mechanism.
###end article-title 159
###begin article-title 160
Factor V Leiden protects against blood loss and transfusion after cardiac surgery.
###end article-title 160
###begin article-title 161
The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
###end article-title 161
###begin article-title 162
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.
###end article-title 162
###begin article-title 163
APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
###end article-title 163
###begin article-title 164
Hypertension as a Risk Factor for Spontaneous Intracerebral Hemorrhage.
###end article-title 164
###begin article-title 165
The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease.
###end article-title 165
###begin article-title 166
Genetic association studies in stroke: methodological issues and proposed standard criteria.
###end article-title 166
###begin article-title 167
Control of confounding of genetic associations in stratified populations.
###end article-title 167
###begin article-title 168
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 168
###begin article-title 169
The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites.
###end article-title 169
###begin article-title 170
Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome.
###end article-title 170
###begin article-title 171
Clinico-epidemiologic study of stroke in Akita, Japan.
###end article-title 171
###begin article-title 172
Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke.
###end article-title 172
###begin article-title 173
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes.
###end article-title 173
###begin p 174
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 174
###begin p 175
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The authors have no support or funding to report.
###end p 175

